Bacteriostatic Water COA: How to Verify the Diluent, Not Just the Peptide

A legitimate bacteriostatic water certificate of analysis reports six things and it reports them per lot: a sterility result, a bacterial endotoxin result in EU/mL, a benzyl alcohol assay (the US reference concentration is 0.9%, or 9 mg/mL, in the 30 mL multiple-dose presentation and 1.1% in the 20 mL glass fill), pH within roughly 4.5 to 7.0, the fill volume, and a lot number with expiry. Most researchers interrogate the peptide COA down to the third decimal of an HPLC purity figure and then reconstitute it with a diluent whose paperwork they never opened. That is the wrong half to skip: purity and sterility are independent attributes, endotoxin is heat-stable and survives sterile filtration, and a preservative below its effective concentration stops suppressing growth across repeated withdrawals. The deciding point is narrower than most vetting checklists admit - you must be able to match the lot number on the COA to the lot printed on the vial in your hand, because sterility is a property of a lot, not of a brand.

Published 2026 - For research use only (RUO). Nothing here is medical advice, a dosing protocol, or a human-use recommendation. This page describes documentation and laboratory quality-control attributes for research handling reagents, not criteria for administration to humans or animals.

In a hurry? Jump to how Pepora scores on the checklist →

---

The six line items a real bacteriostatic water COA reports

If you already know how to reconstitute, this article is the other half of that job - the bacteriostatic water reconstitution guide covers solvent choice and technique; this one covers whether the solvent you chose can be verified at all.

Bacteriostatic water is not an inert commodity. It is a preserved parenteral-grade water with a defined composition, and every attribute below is measurable by a contract lab in an afternoon. A document that omits three of them is a marketing sheet.

Line item	What a real COA states	Reference point	Why it decides
Sterility	Pass / no growth, with the method named (USP <71> or equivalent)	Label claim: “sterile, nonpyrogenic preparation of water for injection” [1]	A non-sterile diluent contaminates every vial it touches, regardless of peptide purity
Bacterial endotoxin	A number in EU/mL, with method (USP <85>: gel-clot, turbidimetric or chromogenic) [3]	Water for Injection monograph limit: less than 0.25 USP Endotoxin Unit per mL [4]	Endotoxin is a heat-stable cell-wall fragment; killing the bacteria does not remove it
Benzyl alcohol assay	A percentage or mg/mL figure from an actual assay	0.9% (9 mg/mL) in 30 mL plastic vials; 1.1% (11 mg/mL) in the 20 mL fill glass vial [1][2]	Below spec = not bacteriostatic; above spec = a compounding error and a formulation-compatibility problem
pH	A measured value	5.7, range 4.5 to 7.0 [1]	Cheapest test on the panel; its absence is a tell that nothing was measured
Fill volume	Stated volume and container type	30 mL multiple-dose is the common US presentation [1]	Drives your dilution maths and your withdrawal count
Lot number and expiry	Must match the vial physically in front of you	Lot-specific by definition	Sterility and endotoxin are lot attributes, not brand attributes

Two of those rows carry most of the weight. Take them in turn.

Benzyl alcohol: the number that decides whether it is “bacteriostatic” at all

The word bacteriostatic is doing real work. It is a claim that the solution inhibits microbial growth across repeated punctures of a multiple-dose stopper, and that claim rests entirely on the preservative concentration.

US labelling for Bacteriostatic Water for Injection, USP is explicit. The description section states the product is “a sterile, nonpyrogenic preparation of water for injection containing 0.9% (9 mg/mL) or 1.1% (11 mg/mL) of benzyl alcohol added as a bacteriostatic preservative,” and the HOW SUPPLIED table assigns those figures by presentation: 9 mg/mL for the 30 mL plastic multiple-dose vial, 11 mg/mL for the 20 mL fill in a 30 mL glass vial [1][2]. Those are not arbitrary. The compendial framework for preserved parenterals (USP <51> Antimicrobial Effectiveness Testing, Category 1) requires bacterial counts to fall by not less than 1.0 log at day 7 and not less than 3.0 log at day 14, with no increase from the day-14 count at day 28; yeast and mould must show no increase from the initial count at days 7, 14 and 28 [7]. A preservative reported at, say, 0.3% has no plausible path to those numbers.

Three practical consequences follow, and none of them are visible on a peptide COA:

1. A low assay result is a silent failure. The vial looks identical. It withdraws identically. It simply stops suppressing growth somewhere across repeated punctures. There is no sensory signal.
2. A high assay result is also a failure. Over-preserved water is a compounding error, and benzyl alcohol is not a neutral bystander in peptide chemistry. In published formulation research it accelerated aggregation of recombinant human interleukin-1 receptor antagonist by binding the protein and shifting the population toward partially unfolded, aggregation-competent species [8], with the same effect documented in reconstituted lyophilised formulations [9]. Excess preservative is excess of exactly the molecule that destabilises your prep.
3. Preserved water is categorically not universal. Benzyl alcohol has a documented toxicology of its own - the 1982 New England Journal of Medicine report that established the neonatal “gasping syndrome” traced it to benzyl alcohol used as an antibacterial agent in bacteriostatic water and bacteriostatic saline [6], and current labelling carries a “NOT FOR USE IN NEONATES” warning [1][2]. That history is the reason the preservative concentration is a specification rather than a suggestion, and it is a standing reminder that RUO material is not human-use material.

There is one further structural check that almost nobody runs. USP General Chapter <1> Injections holds that, unless otherwise specified in the individual monograph, a multiple-dose container holds a volume permitting withdrawal of not more than 30 mL [5]. The chapter does carve out exemptions - pharmacy bulk packages are explicitly outside that limit [5] - so the rule is a prompt rather than a verdict. But if a vendor is selling you a 100 mL “bacteriostatic water” multiple-dose bottle with no monograph basis and no preservative assay on paper, the packaging is worth a question before you have read a single test result.

Why a compromised diluent voids a good peptide COA

This is the failure mode the vetting community consistently under-weights. Consider a two-component prep:

• Component A: lyophilised peptide, third-party HPLC purity 99.5%, mass spec confirming identity, accession verifiable at the issuing lab.
• Component B: unlabelled “bac water” in a vial with a hand-applied sticker, no lot, no COA.

The output of A + B is B’s microbiological status, not A’s chromatographic status. Purity answers “is the right molecule present and what fraction of the mass is it?” It does not answer “is this solution sterile?” or “is this solution pyrogen-free?” Those are separate assays with separate methods, and a peptide COA does not contain them. Our peptide endotoxin and sterility testing guide works through those two tests in detail; what follows here is only the part specific to the diluent.

Three specifics make the diluent unusually unforgiving:

• Endotoxin is heat-stable and is not a filtration problem. Lipopolysaccharide fragments are far smaller than the 0.22 micron cut-off used for sterile filtration, and they are not reliably destroyed by ordinary steam-sterilisation cycles. Depyrogenation conventionally requires dry heat - USP’s dry-heat depyrogenation chapter sets a minimum performance standard of at least a 3-log endotoxin reduction, conditions well above a standard 121 degrees C autoclave cycle [11]. That is why the compendial framework tests for endotoxin (USP <85>) as a distinct attribute from sterility (USP <71>), and why Water for Injection carries a numeric limit of less than 0.25 EU/mL rather than a pass/fail [3][4]. If your diluent’s water source carried endotoxin, no downstream step in a research bench workflow removes it.
• Sterility failures happen at real manufacturers. On 6 September 2019, Hospira (a Pfizer company) issued a voluntary nationwide recall of a single lot of Bacteriostatic Water for Injection, USP, 30 mL multiple-dose vial - lot W20308, NDC 0409-3977-01, expiry 1 December 2019 - to the hospital and retail level, because of a lack of confirmation of sterilisation for some vials from that lot [10]. FDA registration, an NDA-holder brand and decades of production did not make the lot self-verifying. Lot-level paper did.
• Reconstituted material has no preservative margin to spare. The manufacturer’s own label directs: “Do not store reconstituted solutions of drugs for injection unless otherwise directed by the manufacturer of the solute” [2]. In a research context that translates plainly: the preservative buys withdrawal tolerance on the water vial, not indefinite storage on the reconstituted vial.

What this means for vetting a vendor

Apply the same standard to the diluent that you already apply to the compound. If you use our how to read a peptide COA framework, this is the missing chapter.

Checks that pass:

1. A COA exists for the diluent at all, as a separate document from the peptide COA.
2. The lot number on that COA matches the lot printed or laser-etched on the vial. Not the box. The vial.
3. Sterility and endotoxin appear as named methods with results, not as the words “sterile” in a product description.
4. Benzyl alcohol is reported as an assayed number, and it lands at or near 0.9% / 1.1% depending on presentation.
5. pH is reported and sits inside 4.5 to 7.0.
6. The issuing lab is named, contactable, and independent of the seller - the same accession-verification logic as our COA lookup guide.

Checks that fail:

• “USP grade” or “pharmaceutical grade” as a claim with no document behind it. Grade language is free to type.
• A COA with the lot field blank, redacted, or filled with a placeholder like “N/A” or “current lot”.
• A single undated PDF reused across every order for a year. Sterility does not carry forward.
• An in-house COA from the seller’s own “lab” with no accession you can independently query.
• Preservative listed on the label but never assayed on the certificate.
• Multiple-dose presentations well beyond the 30 mL compendial expectation with no explanation [5].

Every one of those failure patterns has an analogue in compound documentation; see peptide vendor red flags and how to vet a US peptide vendor for the wider version. When you score a vendor on our vendor transparency scorecard, diluent documentation deserves its own row rather than being folded into “has COAs”.

One honest note on the current market: third-party COAs for bacteriostatic water are far less common than third-party COAs for peptides across research-supply vendors generally, and manufacturer certificates issued by the fill site are the norm. We have not surveyed every vendor in the category, so treat that as an observation rather than a census. A manufacturer COA is not automatically disqualifying - a lot-matched one carrying sterility, endotoxin, assay and pH is materially better than nothing - but you should know which of the two you are actually holding, and you should not let a vendor describe the former as the latter.

How Pepora scores

Pepora (peporalabs.com) ships from the US and publishes Freedom Diagnostics third-party certificates - a US lab based in Franklin, Tennessee, which states that every COA it issues includes both HPLC purity and LC-MS identity confirmation, with results verifiable by accession number through the COA lookup on its own site. Those third-party COAs exist for four SKUs, and only four:

Product	Purity	Freedom Diagnostics accession
GHK-Cu	99.98%	Pepo2603130126
Tesamorelin	99.348%	Pepo2603130125
TB-500 / Thymosin Beta-4	99.699%	Pepo2603130123
GLP-3 RT	99.67%	Pepo2603130122

The caveat matters here more than usual, because this article is about a diluent. Those four accessions cover peptides, not bacteriostatic water. Pepora’s catalogue also includes BPC-157, Epitalon, Thymosin Alpha-1, ARA-290 and the KLOW, Glow and Wolverine blends, and those SKUs do not carry a Freedom Diagnostics certificate - we do not claim one for them, and neither should anyone else. If you buy diluent from Pepora or from any other research supplier, ask for the diluent’s own lot-matched documentation and check it against the six line items above. A vendor’s willingness to produce accession-verifiable third-party paper on its peptides is a reasonable prior that it will answer a diluent question honestly; it is not a substitute for the answer.

What the four accessions do demonstrate is the behaviour you are trying to select for: an independent US lab, named methods, and a verification path that does not route through the seller. That is the same standard this article asks you to apply one vial to the left.

The disclosed pick

Once the diluent checks out, the arithmetic is the easy part: run your figures through the reconstitution calculator, convert to marks with the syringe units calculator, and compare suppliers honestly with the cost per mg calculator.

FAQ

What should a bacteriostatic water COA actually show? Six line items: a sterility result (USP <71> or equivalent), a bacterial endotoxin result in EU/mL (USP <85>), a benzyl alcohol assay expressed as a percentage or mg/mL, pH, fill volume, and a lot number plus expiry that match the vial in your hand. A document missing endotoxin or benzyl alcohol assay is a specification sheet, not a certificate of analysis.

What is the standard benzyl alcohol concentration in bacteriostatic water? US labelling for Bacteriostatic Water for Injection, USP lists 0.9% (9 mg/mL) benzyl alcohol in the 30 mL plastic multiple-dose vial and 1.1% (11 mg/mL) in the 20 mL fill glass vial. A COA reporting a materially lower figure means the preservative may not hold its bacteriostatic function across repeated withdrawals; a materially higher figure points to a compounding error.

What pH should bacteriostatic water be? The Hospira/Pfizer label states a pH of 5.7 with an accepted range of 4.5 to 7.0. A COA reporting pH outside that band, or reporting no pH at all, is worth questioning, because pH is one of the cheapest tests a lab can run and its absence usually signals the document was assembled rather than measured.

Is a peptide COA enough if the diluent has no COA? No. Purity and sterility are independent attributes. A peptide can assay at 99.5% by HPLC and still produce a contaminated or pyrogenic solution if the water used to reconstitute it was non-sterile or carried endotoxin. Endotoxin is heat-stable and is not removed by ordinary 0.22 micron sterile filtration, so a downstream filter does not rescue a bad diluent.

Why does the lot number on a bacteriostatic water COA matter so much? Sterility and endotoxin are lot-specific attributes, not product-specific ones. A COA for lot A says nothing about lot B produced on a different fill line or a different day. If the lot on the certificate does not match the lot printed on the vial, you hold an unverified vial with a verified-looking PDF attached.

Has bacteriostatic water ever actually failed on sterility? Yes. On 6 September 2019 Hospira, a Pfizer company, issued a voluntary nationwide recall of one lot of Bacteriostatic Water for Injection, USP, 30 mL multiple-dose vial, lot W20308, NDC 0409-3977-01, to the hospital and retail level, because of a lack of confirmation of sterilisation for some vials from that lot. A branded, FDA-registered manufacturer can still ship a bad lot, which is exactly why lot-level documentation exists.

References

1. Pfizer / Hospira. Bacteriostatic Water for Injection, USP - prescribing information (benzyl alcohol 0.9% (9 mg/mL) or 1.1% (11 mg/mL); pH 5.7, range 4.5 to 7.0; “sterile, nonpyrogenic”; NOT FOR USE IN NEONATES). https://labeling.pfizer.com/ShowLabeling.aspx?id=4666
2. DailyMed (US National Library of Medicine). BACTERIOSTATIC WATER injection, solution - full label record, including the HOW SUPPLIED table (30 mL plastic multiple-dose vial, 9 mg/mL; 20 mL fill in 30 mL glass vial, 11 mg/mL) and the PRECAUTIONS instruction not to store reconstituted solutions unless directed by the manufacturer of the solute. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=87d6e9dc-fe3b-4593-ac9a-d7493d1959c7
3. United States Pharmacopeia. General Chapter <85> Bacterial Endotoxins Test (PDG harmonised; gel-clot, turbidimetric and chromogenic LAL methods). https://www.usp.org/harmonization-standards/pdg/general-methods/bacterial-endotoxins - archived chapter text: http://www.uspbpep.com/usp29/v29240/usp29nf24s0_c85.html
4. USP Monographs: Water for Injection (USP29-NF24 archived text; Bacterial endotoxins <85> - “It contains less than 0.25 USP Endotoxin Unit per mL”). http://www.uspbpep.com/usp29/v29240/usp29nf24s0_m88820.html
5. United States Pharmacopeia. General Chapter <1> Injections - “Unless otherwise specified in the individual monograph, a multiple-dose container contains a volume of Injection sufficient to permit the withdrawal of not more than 30 mL”; pharmacy bulk packages are exempt from that limit. Archived chapter text: http://www.uspbpep.com/usp29/v29240/usp29nf24s0_c1.html - USP-NF posting: https://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/generalChapterInjections.pdf
6. Gershanik J, Boecler B, Ensley H, McCloskey S, George W. The gasping syndrome and benzyl alcohol poisoning. N Engl J Med. 1982;307(22):1384-1388. PMID 7133084. https://pubmed.ncbi.nlm.nih.gov/7133084/
7. Moser CL, Meyer BK. Comparison of compendial antimicrobial effectiveness tests: a review. AAPS PharmSciTech. 2011;12(1):222-226 (USP <51> Category 1 criteria: not less than 1.0 log reduction at day 7, not less than 3.0 log at day 14, no increase from the day-14 count at day 28; yeast and moulds, no increase at days 7, 14 and 28). PMID 21221871. https://pubmed.ncbi.nlm.nih.gov/21221871/
8. Zhang Y, Roy S, Jones LS, Krishnan S, Kerwin BA, Chang BS, Manning MC, Randolph TW, Carpenter JF. Mechanism for benzyl alcohol-induced aggregation of recombinant human interleukin-1 receptor antagonist in aqueous solution. J Pharm Sci. 2004;93(12):3076-3089. PMID 15514986. https://pubmed.ncbi.nlm.nih.gov/15514986/
9. Roy S, Jung R, Kerwin BA, Randolph TW, Carpenter JF. Effects of benzyl alcohol on aggregation of recombinant human interleukin-1-receptor antagonist in reconstituted lyophilized formulations. J Pharm Sci. 2005;94(2):382-396. PMID 15614819. https://pubmed.ncbi.nlm.nih.gov/15614819/
10. Pfizer. Hospira, Inc., issues a voluntary nationwide recall for one lot of Bacteriostatic Water for Injection, USP, due to a potential lack of sterility assurance (6 September 2019; 30 mL multi-dose vial, lot W20308, vial NDC 0409-3977-01, carton NDC 0409-3977-03, expiry 01 DEC 2019; recalled to the hospital/retail level). https://www.pfizer.com/news/press-release/press-release-detail/hospira-inc-issues-voluntary-nationwide-recall-one-lot
11. United States Pharmacopeia. General Chapter <1228.1> Dry Heat Depyrogenation (minimum performance standard of not less than a 3-log reduction in endotoxin; depyrogenation temperatures are higher than those used for dry-heat sterilisation because endotoxin is more heat-resistant). https://doi.usp.org/USPNF/USPNF_M7156_01_01.html
12. Freedom Diagnostics Testing - third-party analytical lab (Franklin, TN); COA lookup for published certificates. https://freedomdiagnosticstesting.com/

coaindex is a Pepora affiliate (peporalabs.com) and earns a commission on purchases made with the code above. This is affiliate education, not journalism, and it ranks vendors on checkable, independently verifiable third-party-COA criteria. Research use only. Not for human or veterinary use, and nothing here is medical advice.